Search Results 2871-2880 of 13403 for monoclonal antibody
Dr. Rossoll's Translational Neuroproteomics Laboratory at Mayo Clinic focuses on new treatments for motor neuron and neurodegenerative disease.
Get a closer look at the methodology used by the Mayo Clinic Brain Tumor Patient-Derived Xenograft National Resource for establishing brain tumor PDX lines ...
The Mayo Clinic Brain Tumor Patient-Derived Xenograft National Resource provides a bibliography to help researchers identify other studies that have used ...
Mayo Clinic hematologist Arushi Khurana, M.B.B.S., conducts research to modernize clinical trial eligibility, particularly for diffuse large B-cell ...
During this cancer treatment, radioactive material is placed inside the body. Find out how the treatment is done and who it's for.
RNA sequencing (RNA-seq) was performed on a single biological sample for each patient-derived xenograft model in the Mayo Clinic Brain Tumor Patient-Derived ...
Rochester, Minn. This is a phase 1b/2 study of the safety and efficacy of MLN0128 in combination with exemestane or fulvestrant therapy in women with estrogen ...
The research team led by Craig M. Horbinski, M.D., Ph.D., at Mayo Clinic works on a variety of translational brain tumor projects, including preclinical ...
ROCHESTER, Minn. — A new Mayo Clinic study published in the New England Journal of Medicine has uncovered that an off-the-shelf, dual-antibody therapy can ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.